{"entity":{"id":"nct06527300","kind":"trial","name":"A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer","aka":[],"tldr":"A phase 2 trial of NHWD-870 run by Zhejiang Wenda Pharma Technology LTD., of unknown status on the registry.","summary":"A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer is a phase 2 interventional study registered as NCT06527300 by Zhejiang Wenda Pharma Technology LTD., with 48 participants planned, started 2024-04-25. Conditions recorded: Advanced Solid Tumor (Phase 1). Interventions recorded: NHWD-870 HCl.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06527300","url":"https://clinicaltrials.gov/study/NCT06527300"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["nhwd-870"],"companies":["zhejiang-wenda-pharma"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06527300","phase":"2","setting":"A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer","sponsor":"Zhejiang Wenda Pharma Technology LTD.","enrolled":48,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06527300/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"nhwd-870","kind":"drug","name":"NHWD-870","route":"/drugs/nhwd-870/"}],"company":[{"id":"zhejiang-wenda-pharma","kind":"company","name":"Zhejiang Wenda Pharma","route":"/companies/zhejiang-wenda-pharma/"}]}}